Delivery Order SPE2DB22D1202-SPE2DB25FVFL7
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $22,857.87 to AmerisourceBergen Drug Corp for the supply of Atovaquone-Proguanil 250-100mg tablets (100 count). This competitive, non-set-aside contract utilizes firm fixed pricing and carries an ultimate completion date of July 21, 2025. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order from its corporate office location. The medication is an...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Atovaquone-Proguanil 250-100 tablets in a quantity of 100 units, with a ceiling value of $1,343.16. This contract is structured as a firm fixed-price delivery order with an ultimate completion date of July 25, 2025, and represents a non-competitive set-aside transaction. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $8,058.96 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Atovaquone-Proguanil 250-100 100S on July 22, 2025, with an ultimate completion date of July 23, 2025. This non-set-aside contract represents a small-value pharmaceutical procurement executed through AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The award was fulfilled from the company's place of performance in Conshohocken, Pennsylvania,...
- This is a $13,769.48 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The order is for the supply of 4,565,318,867 units of the prescription drug atovaquone-proguanil 250-100 mg, a malaria treatment. The contract has an ultimate completion date of August 2, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that AmerisourceBergen holds with...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of 4,565,912,417 units of Atovaquone-Proguanil 250-100mg tablets. The contract has a firm-fixed price of $4,079.80 and a completion date of September 25, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and AmerisourceBergen, valued at up to $999,999,999 through December...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,816.08, is for the delivery of atovaquone-proguanil 250-100 mg, a pharmaceutical product used for the prevention and treatment of malaria. The contract is a firm fixed-price delivery order with an ultimate completion date of April 24, 2025. This award is not a set-aside contract,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 100 units of Atovaquone-Proguanil 250-100 mg tablets, a prescription medication used to prevent and treat malaria. The contract has a firm fixed price of $3,083.70 and a period of performance through October 25, 2024. The contract is not designated as a set-aside. AmerisourceBergen...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a wholly-owned subsidiary of AmerisourceBergen Corporation. The $5,423.00 award is for the provision of Atovaquone-Proguanil 250-100 mg tablets, a prescription antimalarial medication, to support military treatment programs and facilities. The delivery order is part of a larger indefinite delivery contract (IDC) with a ceiling value of $999,999,999.00 that serves as the primary...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The order is for the medication Atovaquone-Proguanil 250-100 in quantities of 100 tablets, with a firm fixed price of $1,642.01 and a completion date of July 14, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global...
- This is a $1,871.79 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ATOVAQUONE-PROGUANIL 250-100 100S, a malaria treatment medication. The delivery order has a completion date of July 11, 2025 and is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp also holds a $999,999,999.00...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB25FVFL7Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Atovaquone-Proguanil 250-100mg tablets (100 count) with a contract value of $5,372.64. The award, issued on July 24, 2025, represents a firm fixed-price delivery order with an ultimate completion date of July 25, 2025. This non-set-aside contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Atovaquone-Proguanil is an antimalarial medication used for prevention and treatment of malaria, consistent with federal medical procurement needs supporting military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This comprehensive pharmaceutical supply vehicle enables the company to furnish a broad range of medications, vaccines, and medical supplies to support military healthcare operations globally. The contract reflects AmerisourceBergen's established capability as a major pharmaceutical distributor serving federal medical supply chains, with particular strength in fulfilling competitively awarded delivery orders across diverse therapeutic categories for the Defense Health Agency and related government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.4k | 7/24/25 |